Correspondence 0001104659-23-081206 from GridAI Technologies Corp. (GRDX)

GridAI Technologies Corp.
Date: July 14, 2023 · CIK: 0001604191 · Accession: 0001104659-23-081206

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-272404

Date

July 14, 2023

Author

ROTH CAPITAL PARTNERS, LLC

Form

CORRESP

Company

GridAI Technologies Corp.

Letter

Re:

July 14, 2023

VIA FACSIMILE AND EDGAR

U.S. Securities and Exchange Commission

Division of Corporate Finance

Washington, DC 20549

First Wave BioPharma, Inc.

Registration Statement on Form S-1 (Registration No. 333-272404), as amended – Withdrawal of Acceleration Request

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on July 12, 2023, in which we, acting as placement agent on a best efforts basis in an offering pursuant to the registration statement on Form S-1 (333-272404) (the “Registration Statement”), joined First Wave BioPharma, Inc.’s request for acceleration of the effective date of the above-referenced Registration Statement for July 13, 2023 at 5:00 P.M. (Eastern Time). First Wave BioPharma, Inc. is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

Very truly yours,
ROTH CAPITAL PARTNERS, LLC

Show Raw Text

CORRESP
1
filename1.htm

July 14, 2023

VIA FACSIMILE AND EDGAR

U.S. Securities and Exchange Commission

Division of Corporate Finance

Washington, DC 20549

    Re:

    First Wave BioPharma, Inc.

    Registration Statement on Form S-1 (Registration No. 333-272404), as amended – Withdrawal of Acceleration Request

Ladies and Gentlemen:

Reference is made to our letter,
filed as correspondence via EDGAR on July 12, 2023, in which we, acting as placement agent on a best efforts basis in an offering pursuant
to the registration statement on Form S-1 (333-272404) (the “Registration Statement”), joined First Wave BioPharma,
Inc.’s request for acceleration of the effective date of the above-referenced Registration Statement for July 13, 2023 at 5:00 P.M.
(Eastern Time). First Wave BioPharma, Inc. is no longer requesting that such Registration Statement be declared effective at this time
and we hereby formally withdraw our request for acceleration of the effective date.

    Very truly yours,

    ROTH CAPITAL PARTNERS, LLC

    By:
    /s/ Aaron M. Gurewitz

    Name:
    Aaron M. Gurewitz

    Title:
    President & Head of Investment Bank

SecProbe.io